These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1815431)

  • 1. Amiloride for lung disease in cystic fibrosis.
    Zahaykevich A
    DICP; 1991 Dec; 25(12):1340-1. PubMed ID: 1815431
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertonic saline for cystic fibrosis.
    Zarogiannis S; Hatzoglou C; Gourgoulianis K
    N Engl J Med; 2006 Apr; 354(17):1848-51; author reply 1848-51. PubMed ID: 16642590
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
    Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
    Middleton PG; Geddes DM; Alton EW
    Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    N Engl J Med; 1990 Oct; 323(14):996-8. PubMed ID: 2402269
    [No Abstract]   [Full Text] [Related]  

  • 7. Marine biology. Florida red tide brews up drug lead for cystic fibrosis.
    Potera C
    Science; 2007 Jun; 316(5831):1561-2. PubMed ID: 17569840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents.
    Hirsh AJ
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1445-62. PubMed ID: 12458154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis--from gene to therapy.
    Alton EW; Geddes DM
    Trans Med Soc Lond; 1991-1992; 108():29-34. PubMed ID: 1727002
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ; Sabater JR; Zamurs A; Smith RT; Paradiso AM; Hopkins S; Abraham WM; Boucher RC
    J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cystic fibrosis; pathophysiology of electrolyte transport and potential influence of amiloride].
    Hoekstra MO; van Aalderen WM; Gerritsen J; Knol K; Heymans HS
    Ned Tijdschr Geneeskd; 1992 Oct; 136(43):2117-9. PubMed ID: 1279443
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults.
    Olivier KN; Bennett WD; Hohneker KW; Zeman KL; Edwards LJ; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 1996 Jul; 154(1):217-23. PubMed ID: 8680683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update in cystic fibrosis 2008.
    Ratjen F
    Am J Respir Crit Care Med; 2009 Mar; 179(6):445-8. PubMed ID: 19264980
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertonic saline for cystic fibrosis.
    Aziz I; Kastelik JA
    N Engl J Med; 2006 Apr; 354(17):1848-51; author reply 1848-51. PubMed ID: 16641405
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertonic saline for cystic fibrosis.
    Kuver R; Lee SP
    N Engl J Med; 2006 Apr; 354(17):1848-51; author reply 1848-51. PubMed ID: 16642591
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA
    Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiloride: still a viable treatment option in cystic fibrosis?
    Ratjen F; Bush A
    Am J Respir Crit Care Med; 2008 Dec; 178(12):1191-2. PubMed ID: 19050201
    [No Abstract]   [Full Text] [Related]  

  • 18. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.
    Sood N; Bennett WD; Zeman K; Brown J; Foy C; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 2003 Jan; 167(2):158-63. PubMed ID: 12411282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation.
    Schoenberger M; Althaus M
    Expert Opin Ther Pat; 2013 Oct; 23(10):1383-9. PubMed ID: 23957246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride.
    Witko-Sarsat V; Allen RC; Paulais M; Nguyen AT; Bessou G; Lenoir G; Descamps-Latscha B
    J Immunol; 1996 Sep; 157(6):2728-35. PubMed ID: 8805680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.